Abstract
The instrument to measure the impact of the disease in daily life of patients with valvular disease (IDCV) showed good evidences of reliability and convergent validity in patients with coronary artery disease. However, the IDCV did not correlate with the presence or absence of signs and symptoms, systolic function and ejection fraction (variables that measure cardiac performance) in these…